Monica Diosdado
Memorial Sloan Kettering Cancer Center
5 Papers
8 Citations
Monica Diosdado is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer & Liquid biopsy. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS.
A. Rose Brannon,Gowtham Jayakumaran,Monica Diosdado,Juber Patel,Anna Razumova,Yu Hu,Fanli Meng,Mohammad Haque,Justyna Sadowska,Brian J. Murphy,Tessara Baldi,Ian Johnson,Ryan Ptashkin,Maysun Hasan,Preethi Srinivasan,Anoop Balakrishnan Rema,Ivelise Rijo,Aaron Agarunov,Helen Won,Dilmi Perera,David N Brown,Aliaksandra Samoila,Xiaohong Jing,Erika Gedvilaite,Julie L. Yang,Dennis Stephens,Jenna-Marie Dix,Nicole DeGroat,Khedoudja Nafa,Aijazuddin Syed,Alan Li,Emily S. Lebow,Anita S. Bowman,Donna C. Ferguson,Ying Liu,Douglas A. Mata,Rohit Sharma,Soo-Ryum Yang,Tejus Bale,Jamal Benhamida,Jason C. Chang,Snjezana Dogan,Meera Hameed,Jaclyn F. Hechtman,Christine Moung,Dara S. Ross,Efsevia Vakiani,Chad M. Vanderbilt,Jinjuan Yao,Pedram Razavi,Lillian M. Smyth,Sarat Chandarlapaty,Gopa Iyer,Wassim Abida,James J. Harding,Benjamin A. Krantz,Eileen M. O'Reilly,Helena A. Yu,Bob T. Li,Charles M. Rudin,Luis A. Diaz,David B. Solit,Maria E. Arcila,Marc Ladanyi,Brian Loomis,Dana W.Y. Tsui,Michael F. Berger,Ahmet Zehir,Ryma Benayed +68 more
TL;DR: MSK-ACCESS as mentioned in this paper is an NGS assay for detection of very low frequency somatic alterations in 129 genes and achieved 92% sensitivity in de-novo mutation calling down to 0.5% allele frequency and 99% for a priori mutation profiling.
Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma
David H. Abramson,David H. Abramson,Diana Mandelker,Jasmine H. Francis,Jasmine H. Francis,Ira J. Dunkel,Ira J. Dunkel,A. Rose Brannon,Ryma Benayed,Michael F. Berger,Maria E. Arcila,Marc Ladanyi,Danielle Novetsky Friedman,Gowtham Jayakumaran,Monica Diosdado,Melissa A. Robbins,Dianna Haggag-Lindgren,Neerav Shukla,Michael Walsh,Prachi Kothari,Dana W.Y. Tsui,Dana W.Y. Tsui +21 more
- 01 Mar 2021
TL;DR: In this paper, the authors performed a cross-sectional study of the association of circulating tumor DNA (ctDNA) from retinoblastoma and simulating lesions with disease course.
20
Enhanced specificity of high sensitivity somatic variant profiling in cell-free DNA via paired normal sequencing: design, validation, and clinical experience of the MSK-ACCESS liquid biopsy assay
Angela Rose Brannon,Gowtham Jayakumaran,Monica Diosdado,Juber Patel,Anna Razumova,Yu Hu,Fanli Meng,Mohammad Haque,Justyna Sadowska,Brian J. Murphy,Tessara Baldi,Ian Johnson,Ryan Ptashkin,Maysun Hasan,Preethi Srinivasan,Anoop Balakrishnan Rema,Ivelise Rijo,Aaron Agarunov,Helen Won,Dilmi Perera,David N Brown,Aliaksandra Samoila,Xiaohong Jing,Erika Gedvilaite,Julie L. Yang,Dennis Stephens,Jenna-Marie Dix,Nicole DeGroat,Khedoudja Nafa,Aijazuddin Syed,Alan Li,Emily S. Lebow,Anita S. Bowman,Donna C. Ferguson,Ying Liu,Douglas A. Mata,Rohit Sharma,Soo-Ryum Yang,Tejus Bale,Jamal Benhamida,Jason C. Chang,Snjezana Dogan,Meera Hameed,Jaclyn F. Hechtman,Christine Moung,Dara S. Ross,Efsevia Vakiani,Chad M. Vanderbilt,JinJuan Yao,Pedram Razavi,Lillian M. Smyth,Sarat Chandarlapaty,Gopa Iyer,Wassim Abida,James J. Harding,Benjamin A. Krantz,Eileen M. O'Reilly,Helena A. Yu,Bob T. Li,Charles M. Rudin,Luis A. Diaz,David B. Solit,Maria E. Arcila,Marc Ladanyi,Brian Houck-Loomis,Dana Tsui,Michael F. Berger,Ahmet Zehir,Ryma Benayed +68 more
TL;DR: The experience illustrates the importance of analyzing a matched normal sample when interpreting cfDNA results and highlights the potential of cfDNA profiling to guide treatment selection, monitor treatment response, and identify mechanisms of treatment resistance.
Abstract 1387: Tracking minimal residual disease in post-operative cell-free DNA using MSK-ACCESS
Maysun Hasan,Juber Patel,Ian Johnson,Fanli Meng,Grittney Tam,Xiaohong Jing,Julie L. Yang,A. Rose Brannon,Jayakumaran Gowtham,Dennis Stephens,Monica Diosdado,Ryma Benayed,Ahmet Zehir,Chin-Tung Chen,Martin R. Weiser,Dana W.Y. Tsui,Brian Houck-Loomis,Michael F. Berger +17 more
TL;DR: This study shows that MSK-ACCESS can be used to successfully detect MRD, and has applied it to monitor variants known from tissue tumor sequencing in pre- and post-surgical cfDNA samples from 9 colon adenocarcinoma patients.
2
Abstract 56: MSK-ACCESS Heme: A cell-free DNA next-generation sequencing assay to identify somatic alterations in patients with lymphoma
Sara E DiNapoli,Coleman Spence,Erika Gedvilaite,Anita S. Bowman,Monica Diosdado,Anna Razumova,Dana W.Y. Tsui,Gilles Salles,Connie Lee Batlevi,Gottfried von Keudell,Ryan Ptashkin,Ahmet Zehir,Michael F. Berger,A. Rose Brannon,Ryma Benayed,Maria E. Arcila +15 more
TL;DR: The preliminary validation of MSK-ACCESS Heme (Memorial Sloan Kettering-Analysis of Circulating cfDNA to Examine Somatic Status) is described, a cfDNA assay that employs unique molecular indexing and ultra-deep sequencing to detect somatic alterations in 117 genes related to hematologic malignancies.